Dr. Sriram Subramaniam
-
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
When the next pandemic hits, Canada will be better prepared to respond with homegrown vaccines and therapeutics.
-
UBC researchers discover ‘weak spot’ across major COVID-19 variants
Researchers at the University of British Columbia have discovered a key vulnerability across all major variants of the SARS-CoV-2 virus, including the recently emerged BA.1 and BA.2 Omicron subvariants.
-
UBC scientists unveil world’s first molecular-level analysis of Omicron variant spike protein
UBC researchers are the first in the world to conduct a molecular-level structural analysis of the Omicron variant spike protein.
-
UBC researchers unveil first molecular images of B.1.1.7 COVID-19 mutation
UBC researchers are the first in the world to publish structural images of the N501Y mutation on the SARS-CoV-2 spike protein—a change believed to be partly responsible for the highly infectious nature and rapid spread of variant B.1.1.7.